JIVZX Performance — JPMorgan U.S. Applied Data Science Value Fund, Class R2
Data updated: 2025-09-12
JIVZX returned +11.47% over one year to Jun 2025. Annualised returns are +12.27% over 3 years and +14.59% over 5 years. The fund trailed its US Large Value category average: $100 invested three years ago grew to $142, against $146 for the category, and to $111 over one year, against $112. Volatility over the past three years was 15.17% a year. In the 12 months to Jun 2025 the fund lost a net $25.8M, and assets reached $149.66M.
JIVZX Growth of $100
What $100 invested in JPMorgan U.S. Applied Data Science Value Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Value category average over the same months.
| Period | JIVZX | Category average |
|---|---|---|
| 1 year (Jul 2024 – Jun 2025) | $111 | $112 |
| 3 years (Jul 2022 – Jun 2025) | $142 | $146 |
| 5 years (Jul 2020 – Jun 2025) | $198 | $193 |
| Since data start (Jul 2019 – Jun 2025) | $176 | $185 |
JIVZX Trailing Returns
Total returns to Jun 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +11.47% |
| 3 years (annualised) | +12.27% |
| 5 years (annualised) | +14.59% |
JIVZX Annual Returns
Calendar-year total returns of JPMorgan U.S. Applied Data Science Value Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Jun) | +4.70% |
| 2024 | +14.74% |
| 2023 | +11.48% |
| 2022 | −6.64% |
| 2021 | +30.78% |
| 2020 | +1.04% |
| 2019 (Jul–Dec) | +6.81% |
JIVZX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +4.1% | +1.2% | −3.0% | −3.3% | +2.5% | +3.5% | — | — | — | — | — | — |
| 2024 | +0.8% | +4.1% | +4.6% | −4.1% | +2.7% | −0.4% | +4.5% | +3.4% | +1.0% | −0.4% | +5.4% | −7.1% |
| 2023 | +4.2% | −3.1% | −1.0% | +2.0% | −3.6% | +6.3% | +3.3% | −2.5% | −3.4% | −2.9% | +7.4% | +5.4% |
| 2022 | −1.4% | −1.3% | +2.2% | −5.3% | +2.1% | −8.2% | +6.3% | −2.4% | −8.4% | +9.9% | +6.1% | −4.6% |
| 2021 | −0.3% | +7.7% | +6.3% | +4.9% | +2.6% | −1.7% | +1.1% | +1.6% | −3.5% | +6.0% | −3.3% | +6.5% |
| 2020 | −3.4% | −9.7% | −16.6% | +11.5% | +3.7% | −0.6% | +3.7% | +3.4% | −2.9% | −1.0% | +12.6% | +4.1% |
| 2019 | — | — | — | — | — | — | +0.7% | −3.1% | +2.9% | +1.2% | +2.8% | +2.3% |
JIVZX Risk
Risk measures from monthly returns over Jul 2022 – Jun 2025.
- 3-year volatility (annualised): 15.17%
- 3-year Sharpe ratio: 0.51 (vs 4.5% risk-free rate)
- Best month: +9.94% (Oct 2022)
- Worst month: −8.42% (Sep 2022)
JIVZX Fund Flows
Monthly money in and out of JPMorgan U.S. Applied Data Science Value Fund, from SEC Form N-PORT.
- 12-month net flow: −$25.8M
- 12-month gross sales (incl. reinvestments): $26.9M
- Sales ÷ redemptions: 0.51×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2025 | $1.2M | $14.8M | −$13.6M |
| May 2025 | $819K | $4.0M | −$3.2M |
| Apr 2025 | $789K | $2.5M | −$1.7M |
| Mar 2025 | $1.3M | $2.4M | −$1.1M |
| Feb 2025 | $767K | $3.5M | −$2.7M |
| Jan 2025 | $1.5M | $2.4M | −$872K |
| Dec 2024 | $12.8M | $5.2M | $7.6M |
| Nov 2024 | $1.6M | $2.7M | −$1.1M |
| Oct 2024 | $802K | $3.3M | −$2.5M |
| Sep 2024 | $2.4M | $2.4M | $83K |
| Aug 2024 | $1.5M | $4.7M | −$3.2M |
| Jul 2024 | $1.3M | $4.7M | −$3.4M |
JIVZX Assets Under Management
Net assets of JPMorgan U.S. Applied Data Science Value Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-06-30 | $149.66M |
| 2025-03-31 | $165.08M |
| 2024-12-31 | $166.65M |
| 2024-09-30 | $177.33M |
| 2024-06-30 | $169.34M |
| 2024-03-31 | $178.03M |
| 2023-12-31 | $168.83M |
| 2023-09-30 | $168.22M |
| 2023-06-30 | $177.62M |
| 2023-03-31 | $182.05M |
| 2022-12-31 | $190.07M |
| 2022-09-30 | $179.66M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.